3 FTSE 100 shares I’d snap up for my Stocks and Shares ISA

The FTSE 100 index (INDEXFTSE: UKX) is packed with great shares and here are three that I like.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We’ve recently started a new ISA year, which means you have until 5 April 2020 to invest your £20,000 Stocks and Shares ISA allowance. Here are three share ideas to research.

Pharmaceuticals

Hikma Pharmaceuticals (LSE: HIK) develops manufactures and markets branded, generic and in-license pharmaceutical products. The share price has been volatile over the past few years but the dividend is around 90% higher than it was five years ago.

Chief executive Siggi Olafsson was appointed at the beginning of 2018 and said in last month’s full-year results report that during the year revenue and profits were “significantly ahead” of the directors’ expectations, which I find encouraging. New blood at the top of a company is also something I see as a positive because it can usher in renewed management vigour and determination.

Around 62% of revenue came from the US, 32% from the Middle East and North Africa with the rest from around the world. So, the American market is important to the company. The injectables business delivered 40% of overall revenue with 33% coming from generics, 26% from branded products and the rest from other lines. The outlook is positive.

Broadcasting

ITV (LSE: ITV) is an integrated producer and broadcaster, which creates, owns and distributes content for multiple platforms. The firm operates a commercial family of channels in the UK delivering content through television broadcasting and on multiple platforms, such as the ITV Hub, pay platforms and via direct content deals. There’s also a studios segment producing content covering travel, drama, entertainment and factual formats.

The share price has been weak since the end of 2015 and the valuation looks compelling, including a high dividend yield. The dividend has risen around 130% over the past five years.

Meanwhile, in February’s full-year results report, chief executive Carolyn McCall warned that advertising income would likely be under pressure through 2019 because of economic and political headwinds.”

However, the firm is repositioning the ITV brand, developing its data and digital capabilities, increasing its ability to offer addressable advertising and expanding its direct-to-consumer activities.  Such initiatives could see the firm through any further difficulties. I think the stock is tempting.

Business software

The Sage Group (LSE: SGE) provides integrated accounting, payroll and payments solutions to all types of companies and organisations. Over the past five years, the share price has risen around 75% and the dividend by about 46%. In an update in January, chief executive Steve Hare said 2019 started well, which he puts down to the firm’s “renewed focus” on high-quality subscription and recurring revenue.

During the trading year to September 2018, 54% of overall revenue came from Europe, 31% from North America and the rest from other regions. I’ve always liked the company because its products seem to be everywhere and used by businesses large and small. I think that once a firm adopts the Sage solution, switching costs and inconvenience are high, so many tend to stick with the firm, leading to generally stable inflows of cash for it.

However, the appeal of Sage hasn’t gone unnoticed and the valuation looks full. But I think the business is a quality outfit and deserves its rating.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals, ITV, and Sage Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

If I’d invested £5,000 in a Nasdaq index fund 5 years ago, here’s how much I’d have now

The Nasdaq index keeps hitting new all-time records in 2024, as US tech stocks fly. How much could I have…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

£500 to invest a month? Consider aiming to turn that into a £20,000 passive income like this!

With a regular monthly investment, it's possible to build a large and steady passive income for retirement. Royston Wild explains.

Read more »

Senior Couple Walking With Pet Bulldog In Countryside
Investing Articles

As retirement needs soar 60%, here’s how I’m building wealth with UK shares

A regular investment in UK shares and funds could help Brits create a large and lasting pension. Our writer Royston…

Read more »

Investing Articles

I’d buy Games Workshop shares before they reach the FTSE 100!

Games Workshop shares look likely to join the FTSE 100 soon. Here’s why I think investors should consider buying the…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Could me buying this stock with a $2.5bn market-cap be like investing in Tesla in 2010?

Archer Aviation (NASDAQ:ACHR) stock's nearly doubled so far in November. Could this start-up be another Tesla in the making?

Read more »

Investing Articles

5,000 shares of this UK dividend stock could net me £1,700 a month in passive income

Our writer calculates the passive income he could earn from holding a significant number of shares in this powerful dividend-paying…

Read more »

Investing Articles

9.3%+ yields! 3 FTSE 100 dividend giants to consider buying

Our writer examines a trio of high-yield FTSE 100 shares and explains some of the opportunities and risks he sees…

Read more »

Investing Articles

As the Kingfisher share price drops on Budget fallout, should I buy?

The Kingfisher share price was on a strong 2024 run until the DIY group warned us of the possible effects…

Read more »